Patents Examined by Fereydoun G. Sajjadi
  • Patent number: 8323615
    Abstract: A method for processing multi-phasic dispersions is provided. The method comprises providing a multi-phasic dispersion, the dispersion including dispersed and continuous phases, the dispersion comprising solid microparticles, providing a non-solvent, combining the multi-phasic dispersion and the non-solvent, and selectively effecting migration of the dispersed phase into or through the non-solvent such that the microparticles are separated from the dispersion.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: December 4, 2012
    Assignees: Baxter International Inc., Baxter Healthcare S. A.
    Inventor: Uri Piran
  • Patent number: 8309105
    Abstract: New triflusal-containing polymeric compounds resulting from the polymerization of 2-(methacryloyloxy)ethyl 2-acetyloxy-4-(trifluoromethyl)benzoate with butyl acrylate are described. These new polymers exhibit good adhesion and crack-bridging properties and are particularly suitable for the coating of stents.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: November 13, 2012
    Assignee: Palau Pharma, S.A.
    Inventors: Julio San-Román Del Barrio, Gema Rodríguez Crespo, Mar Fernández Gutiérrez, Alberto Gallardo Ruiz, Luis Duocastella Codina, Maria Molina Crisol
  • Patent number: 8309129
    Abstract: A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug, ethylcellulose, and a bile salt.
    Type: Grant
    Filed: April 21, 2008
    Date of Patent: November 13, 2012
    Assignee: Bend Research, Inc.
    Inventors: Warren Kenyon Miller, Michael Mark Morgen, Daniel Tod Smithey
  • Patent number: 8303982
    Abstract: A medical patch system has a first medical patch including an outer locating ring securable to a surface and an inner patch, separable from the outer locating ring, disposed within the outer locating ring. The medical patch system includes a second medical patch adapted for insertion into the central area bounded by the outer locating ring after the inner patch is separated from the outer locating ring. The second medical patch includes a second outer locating ring securable to the surface, and a second inner patch section, separable from the second outer locating ring, disposed within a second central area bounded by the second outer locating ring. The first and second outer locating rings have adhesive layers for securing the outer locating rings to a surface. The adhesive layers on the respective outer locating rings have different sizes, shapes or patterns to minimize skin irritation.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: November 6, 2012
    Assignee: Ethicon, Inc
    Inventors: Daniel J. Smith, Jessica Liberatore
  • Patent number: 8293285
    Abstract: A composition comprises an ion-exchanged carrageenan. The carrageenan may be a traditionally extracted or neutrally extracted iota or kappa carrageenan. The ion-exchanged carrageenan has reduced gelling cation contents, reduced gelling temperature, and reduced melting temperature, as compared to its non-ion-exchanged counterpart. The ion-exchanged carrageenan may be mixed with another carrageenan to form a carrageenan product having a unique gelling temperature and melting temperature. Also disclosed is a process for making an ion-exchanged carrageenan composition.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: October 23, 2012
    Assignee: CP Kelco U.S., Inc.
    Inventor: Jens Eskil Trudsoe
  • Patent number: 8287910
    Abstract: The present invention provides micelles having a polynucleotide encapsulated therein, the micelle comprising copolymers comprising hydrophobic moieties in a cationic complexing block. The invention further provides methods of preparing and using said micelles, and compositions thereof.
    Type: Grant
    Filed: April 29, 2010
    Date of Patent: October 16, 2012
    Assignee: Intezyne Technologies, Inc.
    Inventors: Janni Mirosevich, Gregoire Cardoen, Kevin N. Sill, Habib Skaff
  • Patent number: 8282959
    Abstract: Branched end reactants having two or three functional groups at the ends are disclosed. The branched end reactants are used to prepare crosslinked hydrogel tissue adhesives, which have a good balance of mechanical properties in an aqueous environment. Kits comprising the branched end reactants and methods for applying a coating to an anatomical site on tissue of a living organism are also disclosed.
    Type: Grant
    Filed: November 27, 2007
    Date of Patent: October 9, 2012
    Assignee: Actamax Surgical Materials, LLC
    Inventors: Samuel David Arthur, Garret D. Figuly
  • Patent number: 8283291
    Abstract: The present invention relates to a herbicidal composition having a synergistic herbicidal effect against weeds, said herbicidal composition including 3-[(5-difluoromethoxy-1-methyl-3-trifluoromethylpyrazol-4-yl)methylsulfonyl]-4,5-dihydro-5,5-dimethylisoxazole and salts thereof as a component A and a component B selected from the group consisting of paraquat, ametryn, acetochlor, clodinafop-propargyl, diclofop-methyl, cycloxydim, tepraloxydim, tralkoxydim, amidosulfuron, mesosulfuron-methyl, sulfosulfuron, tribenuron-methyl, imazamethabenz-methyl, imazamox, imazapic, florasulam, hexazinone, chlorotoluron, pyraflufen-ethyl, metazachlor, S-metolachlor, isoxaben, fluroxypyr, qinclorac and pinoxaden.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: October 9, 2012
    Assignee: Kumiai Chemical Industry Co., Ltd.
    Inventors: Yoshihiro Yamaji, Hisashi Honda, Masanori Kobayashi, Ryo Hanai
  • Patent number: 8278350
    Abstract: An agent for skin external use of the invention contains a salt of higher fatty acid ester of ascorbic acid-2-phosphoric acid ester and a polyhydric alcohol. According to the present invention, occurrence of turbidity or precipitation with time can be prevented to enhance stability even when the agent for skin external use is prepared using a specific salt of higher fatty acid ester of ascorbic acid-2-phosphoric acid ester. Therefore, the present invention is useful for all agents for skin external use, particularly cosmetics.
    Type: Grant
    Filed: October 13, 2004
    Date of Patent: October 2, 2012
    Assignee: Showa Denko K.K.
    Inventors: Eiko Kato, Tadashi Yoneda, Eiji Ogata
  • Patent number: 8278245
    Abstract: The present invention relates to aqueous-containing pesticide concentrates containing an ionic nitrate salt additive as a corrosion inhibitor as well as pesticide compositions prepared from these concentrates and to the use of said compositions for controlling pests.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: October 2, 2012
    Assignee: Syngenta Crop Protection LLC
    Inventors: Michael Hopkinson, Giulia Capuzzi, Sarah Cush, Carolyn Moore
  • Patent number: 8278360
    Abstract: Provided are a behavior-disrupting agent of Argentine ants for controlling them or suppressing their reproduction is a safer and more effective manner, and the behavior-disrupting method of them. More specifically, a behavior-disrupting agent of Argentine ants comprising Z-9-hexadecenal, and a behavior-disrupting method of Argentine ants comprising a step of using the behavior-disrupting agent are provided based on the finding that the behavior of Argentine ants is disrupted by emission of Z-9-hexadecenal, which is a trail pheromone, into the atmosphere.
    Type: Grant
    Filed: February 23, 2005
    Date of Patent: October 2, 2012
    Assignee: Shin-Etsu Chemical Co., Ltd.
    Inventors: Sadahiro Tatsuki, Mamoru Terayama, Yasutoshi Tanaka, Takehiko Fukumoto
  • Patent number: 8268749
    Abstract: Aqueous herbicidal glyphosate compositions are provided, particularly sprayable, ready-to-use (RTU) formulations that are capable of inducing early visually apparent phytotoxic effects while minimizing antagonism to the glyphosate component of the composition and preserving the equally desirable attribute of prolonged control of the treated plants. The compositions combine a glyphosate component and a fatty acid component as a fast symptomology active ingredient and, in one embodiment, are enhanced by the concentration of the fatty acid component utilized and the inclusion of an agronomically acceptable inorganic ammonium salt, preferably ammonium sulfate. In another embodiment, the compositions of the present invention include a nonionic surfactant component comprising certain water-soluble, alkoxylated alcohols.
    Type: Grant
    Filed: September 15, 2005
    Date of Patent: September 18, 2012
    Assignee: Monsanto Technology LLC
    Inventors: Daniel R. Wright, Joseph J. Sandbrink, Paul G. Ratliff, Bryan A. Kliewer, Dawn Y. Wyse-Pester
  • Patent number: 8268895
    Abstract: The present invention concerns the use as perfuming ingredient, for instance to impart odor notes of the floral and/or green type, of a compound of formula 5 wherein R is an ortho, meta or para substituent of the phenyl, and represents a hydrogen atom or a C 1-2 alkyl or alkoxyl group; R 1 represents a hydrogen atom or a methyl or ethyl group; 10 R 2 represents a hydrogen atom or a C 1-3 alkyl group; and X represents a CHO, COOR 3, CH(OR 4) 2 or CN group, R 3 being a methyl or ethyl group, and R 4, taken seperately, being a methyl or ethyl group, or said R 4, taken together, a C 2-5 alkanediyl group; and at least one of said R, R 1 or R 2 represents a group containing at least one carbon atom.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: September 18, 2012
    Assignee: Firmenich SA
    Inventor: Robert Moretti
  • Patent number: 8268332
    Abstract: The present invention encompasses methods that use heat and/or electromagnetic radiation for dermatological treatment and more particularly to a method that uses heat and/or electromagnetic radiation in combination with chromophores for fractional wounding and, in particular, discontinuous fractional damage of skin tissue.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: September 18, 2012
    Assignee: The General Hospital Corporation
    Inventor: Dieter Manstein
  • Patent number: 8263526
    Abstract: The combination of keratin hydrolysate with viable cells or infectious propagules of a fungal biological control agent such as Paecilomyces species, Metarhizium species, Beauveria species, and/or Verticillium species, provides effective control of soil-dwelling or subterranean insects, including termites, and particularly those belonging to the family Rhinotermitidae, such as the Formosan subterranean termite and native North American subterranean termites. In use, a foam-forming composition comprising the keratin hydrolysate and an insecticidally effective amount of the fungus are applied to the insects, the locus of the insects, to material susceptible to infestation by said insects, or to the locus of material susceptible to infestation by said insects.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: September 11, 2012
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Christopher A. Dunlap, Mark A. Jackson, Maureen S. Wright
  • Patent number: 8263058
    Abstract: A personal care composition is provided that comprises a hydrophilic liquid, a structurant for the hydrophilic liquid, a surface active, a lipid, and an aqueous phase. The lipid, hydrophilic liquid, structurant, and surface active are included in a lipid phase. The hydrophilic liquid, structurant, and surface active are connected to the lipid in the lipid phase. These compositions provide improved skin and/or hair moisturization, appearance, aesthetics and skin and/or hair conditioning during and/or after application, and are useful in providing improved deposition to the desired area of the skin and/or hair. A method of using the personal care composition is also provided.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: September 11, 2012
    Assignee: The Procter & Gamble Company
    Inventors: Qing Stella, Steven Hardy Page, Mark Leslie Kacher, Karl Shiqing Wei, Magda El-Nokaly
  • Patent number: 8263045
    Abstract: A sunless tanning composition having dihydroacetone and an amphoglycinate (amphoacetate) in an amount effective for sunless tanning is provided. Also provided is a method of sunless tanning having the step of topically applying to the skin an effective amount of a sunless tanning composition having dihydroacetone and an amphoglycinate.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: September 11, 2012
    Assignee: Playtex Products, Inc.
    Inventors: Olga Dueva-Koganov, Thomas Russo, James P. Sanogueira
  • Patent number: 8258181
    Abstract: The NSAID, sulindac and/or its metabolites and derivatives, in combination with hydrogen peroxide or another oxidizing agent, such as arsenic trioxide that generates reactive oxygen species (ROS), significantly enhances the killing of cancer cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against cancer cells. A skin cream has been developed and used to treat skin cancer and precancerous skin growths that effectively removes the lesions with no effect on surrounding normal skin.
    Type: Grant
    Filed: March 23, 2006
    Date of Patent: September 4, 2012
    Assignee: Florida Atlantic University
    Inventors: Herbert Weissbach, Lionel Resnick, David Binninger
  • Patent number: 8258164
    Abstract: An aqueous nitroimidazole composition comprises metronidazole, tinidazole or a combination thereof at a concentration greater than the solubility of the free base form of the nitroimidazole in water at 20° C., and a nitroimidazole crystallization-inhibiting amount of at least one organic acid. The organic acid preferably is a lower alkyl carboxylic acid (e.g., acetic acid), a polybasic acid (e.g., citric acid, tartaric acid, malic acid, polyacrylic acid, and the like), or a combination thereof. The composition can further include a thickening agent, to form a gel. The composition is free from organic co-solvents, water-soluble vitamins, and cyclodextrins; and free from nitroimidazole crystals at an ambient temperature of about 20° C. Methods of preparing the composition are also described.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: September 4, 2012
    Assignee: Curatek Pharmaceuticals Holding, Inc.
    Inventors: Robert J. Borgman, James E. Juul
  • Patent number: 8252723
    Abstract: The invention relates to the use of compounds of the formula (I) or salts thereof in which R1, R2, R3, R4, R5, R6 and n are as defined in claim 1 as herbicides and plant growth regulators. The invention also relates to novel compounds of the formula (I) and salts thereof (see claim 5).
    Type: Grant
    Filed: December 27, 2007
    Date of Patent: August 28, 2012
    Assignee: Bayer CropScience AG
    Inventors: Harald Jakobi, Oswald Ort, Martin Hills, Heinz Kehne, Christopher Rosinger, Dieter Feucht